Atossa Therapeutics has issued common stock purchase warrants exercisable beginning December 12, 2026, with terms defined in a June 10, 2026 Securities Purchase Agreement. The warrants allow holders to purchase company common stock at specified exercise prices through termination dates based on warrant series.